{"date":"2025-02-20","count":17,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1752-2025-02-20-1845-1j719w9","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2025-02-20","time":"18:45:46","subject":"董事會決議113年股利分派","clause":"第14款","fact_date":"2025-02-20","cite_as":"公開資訊觀測站重大訊息：南光（1752），2025-02-20 18:45，「董事會決議113年股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2025-02-20-1743-t4w9fn","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2025-02-20","time":"17:43:42","subject":"公告本公司董事會通過113年第四季合併財務報告","clause":"第31款","fact_date":"2025-02-20","cite_as":"公開資訊觀測站重大訊息：南光（1752），2025-02-20 17:43，「公告本公司董事會通過113年第四季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2025-02-20-1741-tulf6t","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2025-02-20","time":"17:41:49","subject":"公告本公司董事會決議召開114年股東常會相關事宜","clause":"第17款","fact_date":"2025-02-20","cite_as":"公開資訊觀測站重大訊息：南光（1752），2025-02-20 17:41，「公告本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2025-02-20-1731-1sldsev","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2025-02-20","time":"17:31:14","subject":"本公司董事會決議召開114年第1次股東臨時會相關事宜。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2025-02-20 17:31，「本公司董事會決議召開114年第1次股東臨時會相關事宜。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2025-02-20-1719-1muo30n","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2025-02-20","time":"17:19:29","subject":"公告本公司辦理股票初次上櫃過額配售內容","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2025-02-20 17:19，「公告本公司辦理股票初次上櫃過額配售內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2025-02-20-1718-8ujb8r","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2025-02-20","time":"17:18:46","subject":"公告本公司股票初次上櫃前現金增資收足股款暨現金增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2025-02-20 17:18，「公告本公司股票初次上櫃前現金增資收足股款暨現金增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2025-02-20-1651-z6rxem","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2025-02-20","time":"16:51:38","subject":"公告本公司股票初次上櫃前現金增資發行新股承銷價格","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2025-02-20 16:51，「公告本公司股票初次上櫃前現金增資發行新股承銷價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-02-20-1640-o0aovs","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-02-20","time":"16:40:55","subject":"公告本公司背書保證達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第四款之公告標準","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-02-20 16:40，「公告本公司背書保證達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第四款之公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-02-20-1640-1m1q0jp","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-02-20","time":"16:40:39","subject":"代子公司TDW HK Limited公告董事會決議增資迪瑞藥業(成都)有限公司","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-02-20 16:40，「代子公司TDW HK Limited公告董事會決議增資迪瑞藥業(成都)有限公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-02-20-1640-19jxlpw","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-02-20","time":"16:40:24","subject":"公告本公司擬增資100%子公司TDW HK Limited","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-02-20 16:40，「公告本公司擬增資100%子公司TDW HK Limited」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-02-20-1640-qeifnh","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-02-20","time":"16:40:08","subject":"公告本公司董事會通過現金增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-02-20 16:40，「公告本公司董事會通過現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-02-20-1639-11zoorj","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-02-20","time":"16:39:46","subject":"公告本公司董事會通過114年股東常會召開相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-02-20 16:39，「公告本公司董事會通過114年股東常會召開相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-02-20-1639-f19n2i","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-02-20","time":"16:39:31","subject":"董事會決議發行114年度員工認股權憑證","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-02-20 16:39，「董事會決議發行114年度員工認股權憑證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-02-20-1639-12xpldd","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-02-20","time":"16:39:03","subject":"公告董事會決議取消對迪瑞藥業(成都)有限公司之以債轉股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-02-20 16:39，「公告董事會決議取消對迪瑞藥業(成都)有限公司之以債轉股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-02-20-1446-om6vk9","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-02-20","time":"14:46:52","subject":"公告本公司董事會決議第二次買回庫藏股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-02-20 14:46，「公告本公司董事會決議第二次買回庫藏股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-02-20-1346-p67uuk","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-02-20","time":"13:46:29","subject":"公告本公司內部稽核主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-02-20 13:46，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2025-02-20-0841-1pp14n8","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-02-20","time":"08:41:17","subject":"補充說明本公司近期多位人員異動案之影響及因應措施","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-02-20 08:41，「補充說明本公司近期多位人員異動案之影響及因應措施」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}